Background: Circulating tumor cells (CTCs) are cells that break away from either the primary tumor or metastatic sites and circulate in the peripheral blood. We developed a CTC capture technology known as Vortex Chip, which allows for rapid isolation of highly purified CTCs in a matter of minutes. Moreover, because the Vortex Chip isolates CTCs based on their size, our chip does not require antibody based capture that can potentially bias the isolation of CTC subpopulations to cells that express a specific surface marker (i.e. epithelial cell adhesion molecule [EpCAM]). We had previously designed the Vortex HT chip for higher sample throughput and have utilized this chip for capture of patient samples. We have also designed a new version of the Vortex Chip, Vortex Chip HE (i.e. Higher Efficiency), that manifests increased capture efficiency, which has improved our ability to successfully and more consistently perform molecular studies such as exome and gene specific sequencing. We also assessed the potential for epithelial-mesenchymal transitions in the tumor through immunostaining of the isolated CTCs.
